过敏性疾病：对风险因素、免疫机制、与COVID-19的联 系、潜在治疗方法和过敏原生物信息学作用的全面回顾

哈立 德·¹, 法哈 德·²
1、公共卫生部
2、健康科学大学

摘要

过敏性疾病的流行被认为是全球健康面临的主要挑战之一。尽管这种流行率迅速增加的确切机制尚不清楚，
但新出现的证据表明遗传和环境因素起着重要作用。近年来，免疫系统、微生物群、病毒和细菌都与过敏性疾病的
发作有关。避免接触过敏原是最好的治疗选择；但是，也使用类固醇、抗组胺药和其他缓解症状的药物。过敏原生
物信息学包括用于管理、存档和分析过敏数据的计算工具 /方法和过敏原相关数据资源。本研究重点介绍了过敏原生
物信息学中的过敏促进机制、算法和概念，以及过敏学领域未来研究的主要领域。

关键词

过敏；免疫系统；微生物群；过敏学；过敏原生物信息学

参考

[1]Woodfolk J.A., Commins S.P., Schuyler A.J., Erwin

E.A., Platts-Mills T.A. Allergens, sources, particles, and

molecules: Why do we make IgE responses? Allergol. Int.

2015;64:295–303. doi: 10.1016/j.alit.2015.06.001.

[2]Genuneit J., Seibold A.M., Apfelbacher C.J.,

Konstantinou G.N., Koplin J.J., La Grutta S., Logan K., Perkin

M.R., Flohr C. The Task Force ‘Overview of Systematic

Reviews in Allergy Epidemiology (OSRAE)’ of the EAACI

Interest Group on Epidemiology. Overview of systematic

reviews in allergy epidemiology. Allergy. 2017;72:849–856.

doi: 10.1111/all.13123.

[3]Morgenstern V., Zutavern A., Cyrys J., Brockow I.,

Koletzko S., Kramer U., Behrendt H., Herbarth O., von Berg A.,

Bauer C.P. Atopic diseases, allergic sensitization, and exposure

to traffic-related air pollution in children. Am. J. Respir. Crit.

Care Med. 2008;177:1331–1337. doi: 10.1164/rccm.200701-

036OC.

[4]Sharma N., Patiyal S., Dhall A., Pande A., Arora C.,

Raghava G.P. AlgPred 2.0: An improved method for predicting

allergenic proteins and mapping of IgE epitopes. Brief.

Bioinform. 2021;22:bbaa294. doi: 10.1093/bib/bbaa294.

[5]Isaacs K.K., Goldsmith M.-R., Egeghy P., Phillips

K., Brooks R., Hong T., Wambaugh J.F. Characterization

and prediction of chemical functions and weight fractions

in consumer products. Toxicol. Rep. 2016;3:723–732. doi:

10.1016/j.toxrep.2016.08.011.

[6]Tanno LK, Chalmers RJ, Calderon MA, Aymé S,

Demoly P., on behalf the Joint Allergy Academies. Reaching

multidisciplinary consensus on classification of anaphylaxis for

the eleventh revision of the World Health Organization's (WHO)

International Classification of Diseases (ICD-11). Orphanet J

Rare Dis. 2017 Mar 16;12(1):53.

[7]Le M, Gabrielli S, Clarke A, Eisman H, Morris

J, Gravel J, Chan ES, Lim R, O'Keefe A, Shand G, BenShoshan M. Emergency Management of Anaphylaxis Due to an

Unknown Trigger: An 8-Year Follow-Up Study in Canada. J

Allergy Clin Immunol Pract. 2019 Apr;7(4):1166-1173.e1.

[8]Anagnostou K. Anaphylaxis in Children: Epidemiology,

Risk Factors and Management. Curr Pediatr Rev.

2018;14(3):180-186.

[9]Schatz M, Sicherer SH, Khan D, Zeiger RS. The

Journal of Allergy and Clinical Immunology: In Practice 2018

Highlights. J Allergy Clin Immunol Pract. 2019 Feb;7(2):393-

411.

[10]Klimek L, Sperl A, Worm M, Ring J. [Anaphylaxis -

Causes, therapy and prevention]. MMW Fortschr Med. 2017

Nov;159(Suppl 3):76-84.